BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 222448)

  • 1. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
    Yamamura Y; Sakatani M; Ogura T; Azuma I
    Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
    Ogura T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):649-57. PubMed ID: 7029149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
    Matsuda M; Morishita T; Horai T; Ikegami H; Nakamura S; Nishio H
    Gan No Rinsho; 1983 Aug; 29(9):955-61. PubMed ID: 6620573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
    Grant SC; Kris MG; Houghton AN; Chapman PB
    Clin Cancer Res; 1999 Jun; 5(6):1319-23. PubMed ID: 10389914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy.
    Hayashi A; Nishida Y; Yoshii S; Kim SY; Uda H; Hamasaki T
    Cancer Sci; 2009 Oct; 100(10):1991-5. PubMed ID: 19656158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
    Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer.
    Yamamura Y; Ogura T; Sakatani M; Hirao F; Kishimoto S; Fukuoka M; Takada M; Kawahara M; Furuse K; Kuwahara O
    Cancer Res; 1983 Nov; 43(11):5575-9. PubMed ID: 6616485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer].
    Yasumoto K; Ichinose Y; Yaita H; Tanaka K; Hara N; Ohta M; Hirota N; Nomoto K; Inokuchi K; Yamamura Y
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):321-7. PubMed ID: 6325864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
    Morishita M
    Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
    [No Abstract]   [Full Text] [Related]  

  • 16. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial.
    Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS
    Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of human lung cancer with BCG cell-wall skeleton.
    Yasumoto K; Manabe H; Ueno M; Ohta M; Ueda H
    Gan; 1976 Dec; 67(6):787-95. PubMed ID: 798710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural BCG in postsurgical stage I non-small cell lung cancer.
    Macchiarini P; Mussi A; Angeletti CA
    Anticancer Res; 1989; 9(2):391-3. PubMed ID: 2546484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.